D.E. Shaw & Co’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60,000
Closed -$1.05M 6154
2021
Q4
$1.05M Sell
60,000
-46,400
-44% -$900K ﹤0.01% 3893
2021
Q3
$2.15M Buy
106,400
+86,400
+432% +$2.22M ﹤0.01% 2969
2021
Q2
$661K Buy
+20,000
New +$755K ﹤0.01% 3866

D.E. Shaw & Co's ONEM Position: Q1 2023 in Review

D.E. Shaw & Co sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 15,797 shares — an estimated $264K sold.

D.E. Shaw & Co first reported a position in ONEM in Q1 2021 and held it in 7 quarters. The position peaked at $3.45M in Q2 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • D.E. Shaw & Co reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,797 1Life Healthcare shares in Q1 2023, an estimated $264K.
  • D.E. Shaw & Co first reported a position in 1Life Healthcare in Q1 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's 1Life Healthcare position peaked at $3.45M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.